Ambrish Singh, BPharma, MTech

PhD Student
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, Australia

With a decade-long tenure in consulting, MedTech, and pharmaceutical industries, I work in the field of Real World Evidence (RWE) Systematic Literature Review (SLR), Meta-analysis (MA), Health Economics & Outcomes Research (HEOR), and Health Technology Assessment (HTA). My expertise spans observation studies, evidence synthesis, international HTA, and market access strategies. I have authored over 30 peer-reviewed publications and hold a PhD in epidemiology and health economics. YOu can follow me on Twitter @ambrishagastya

Poster(s):

• (155) Cost-Effectiveness of Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma in Canada
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT

• (169) Association Between Trajectory of Metabolic Syndrome and Knee Pain over 11 Years in Middle-aged Adults: Evidence from Childhood Determinants of Adult Health (CDAH) Study
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT